Search
Confirm
Cancel
News

News

Location:
Homepage
-
-
-
[Chinese Medicine List] "2021 China Chinese Medicine R&D Strength Ranking TOP50" is grandly released!

[Chinese Medicine List] "2021 China Chinese Medicine R&D Strength Ranking TOP50" is grandly released!

  • Categories:Industry News
  • Author:
  • Origin: 药智新闻
  • Time of issue:2021-09-24
  • Views:

(Summary description)In recent years, the state has vigorously supported and promoted the development of Chinese medicine, put the development of Chinese medicine in a prominent position, made many decisions and deployments, and issued supporting policies for the Chinese medicine science and technology industry. "Guiding Opinions on the Integrated Development of Chinese Medicine Health Services and the Internet" and the "Traditional Chinese Medicine Law" guide the development of the Chinese medicine industry to 2020. The "Administrative Measures for Drug Registration" and "Registration Classification and Application Information Requirements for Chinese Medicines" put forward new requirements for the research and development of new Chinese medicines. All have pointed out the direction for the inheritance and innovation of traditional Chinese medicine, and promoted "the revitalization and development of traditional Chinese medicine usher in a great opportunity for the right time, the right place, and the harmony of people." In addition, as the aging population increases, people’s health awareness of prevention is better than cure, prevention before disease and prevention of changes in existing diseases. Traditional Chinese medicine with the unique advantages of "preventing diseases" will usher in a good opportunity for development, especially in 2020. The indispensable and important role of Chinese medicine in the prevention and treatment of major diseases demonstrated in the fight against the new crown epidemic has brought new development opportunities for the research and development of new Chinese medicines, and also ushered in opportunities for the revitalization of the development of Chinese medicine and the international development. In fact, discovering the treasures of the motherland’s medicine, inheriting the essence of innovative Chinese medicine, promoting the R&D and industrial development of Chinese medicine with technological innovation, and developing “effective and high-quality” new Chinese medicines. Pharmaceutical companies regard it as an important mission to achieve their own innovation and upgrade, enhance core competitiveness, and revitalize the development of traditional Chinese medicine. On September 18, 2021, the "2021 High-Quality Development Conference of the Big Health Industry and the Sixth China Pharmaceutical Research and Development Innovation Summit (PDI)" released the "2021 China TCM R&D Strength Ranking List TOP50" (hereinafter referred to as the "Chinese Medicine List"" ), 50 leading Chinese medicine innovation frontiers.

[Chinese Medicine List] "2021 China Chinese Medicine R&D Strength Ranking TOP50" is grandly released!

(Summary description)In recent years, the state has vigorously supported and promoted the development of Chinese medicine, put the development of Chinese medicine in a prominent position, made many decisions and deployments, and issued supporting policies for the Chinese medicine science and technology industry. "Guiding Opinions on the Integrated Development of Chinese Medicine Health Services and the Internet" and the "Traditional Chinese Medicine Law" guide the development of the Chinese medicine industry to 2020. The "Administrative Measures for Drug Registration" and "Registration Classification and Application Information Requirements for Chinese Medicines" put forward new requirements for the research and development of new Chinese medicines. All have pointed out the direction for the inheritance and innovation of traditional Chinese medicine, and promoted "the revitalization and development of traditional Chinese medicine usher in a great opportunity for the right time, the right place, and the harmony of people."

In addition, as the aging population increases, people’s health awareness of prevention is better than cure, prevention before disease and prevention of changes in existing diseases. Traditional Chinese medicine with the unique advantages of "preventing diseases" will usher in a good opportunity for development, especially in 2020. The indispensable and important role of Chinese medicine in the prevention and treatment of major diseases demonstrated in the fight against the new crown epidemic has brought new development opportunities for the research and development of new Chinese medicines, and also ushered in opportunities for the revitalization of the development of Chinese medicine and the international development.

In fact, discovering the treasures of the motherland’s medicine, inheriting the essence of innovative Chinese medicine, promoting the R&D and industrial development of Chinese medicine with technological innovation, and developing “effective and high-quality” new Chinese medicines. Pharmaceutical companies regard it as an important mission to achieve their own innovation and upgrade, enhance core competitiveness, and revitalize the development of traditional Chinese medicine.

On September 18, 2021, the "2021 High-Quality Development Conference of the Big Health Industry and the Sixth China Pharmaceutical Research and Development Innovation Summit (PDI)" released the "2021 China TCM R&D Strength Ranking List TOP50" (hereinafter referred to as the "Chinese Medicine List"" ), 50 leading Chinese medicine innovation frontiers.

  • Categories:Industry News
  • Author:
  • Origin: 药智新闻
  • Time of issue:2021-09-24 10:38
  • Views:
Information

In recent years, the state has vigorously supported and promoted the development of Chinese medicine, put the development of Chinese medicine in a prominent position, made many decisions and deployments, and issued supporting policies for the Chinese medicine science and technology industry. "Guiding Opinions on the Integrated Development of Chinese Medicine Health Services and the Internet" and the "Traditional Chinese Medicine Law" guide the development of the Chinese medicine industry to 2020. The "Administrative Measures for Drug Registration" and "Registration Classification and Application Information Requirements for Chinese Medicines" put forward new requirements for the research and development of new Chinese medicines. All have pointed out the direction for the inheritance and innovation of traditional Chinese medicine, and promoted "the revitalization and development of traditional Chinese medicine usher in a great opportunity for the right time, the right place, and the harmony of people."

In addition, as the aging population increases, people’s health awareness of prevention is better than cure, prevention before disease and prevention of changes in existing diseases. Traditional Chinese medicine with the unique advantages of "preventing diseases" will usher in a good opportunity for development, especially in 2020. The indispensable and important role of Chinese medicine in the prevention and treatment of major diseases demonstrated in the fight against the new crown epidemic has brought new development opportunities for the research and development of new Chinese medicines, and also ushered in opportunities for the revitalization of the development of Chinese medicine and the international development.

In fact, discovering the treasures of the motherland’s medicine, inheriting the essence of innovative Chinese medicine, promoting the R&D and industrial development of Chinese medicine with technological innovation, and developing “effective and high-quality” new Chinese medicines. Pharmaceutical companies regard it as an important mission to achieve their own innovation and upgrade, enhance core competitiveness, and revitalize the development of traditional Chinese medicine.

On September 18, 2021, the "2021 High-Quality Development Conference of the Big Health Industry and the Sixth China Pharmaceutical Research and Development Innovation Summit (PDI)" released the "2021 China TCM R&D Strength Ranking List TOP50" (hereinafter referred to as the "Chinese Medicine List"" ), 50 leading Chinese medicine innovation frontiers.

Related News

WeChat

福森药业

Copyright © 2021 Fusen Pharmaceutical Company Limited

豫ICP备2021028871号  Powered by www.300.cn

Copyright © 2021 Fusen Pharmaceutical  All Rights Reserved.      豫ICP备2021028871号        Powered by www.300.cn